GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (FRA:F0U) » Definitions » Short-Term Capital Lease Obligation

Navco Pharmaceuticals (FRA:F0U) Short-Term Capital Lease Obligation : €0.00 Mil (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Navco Pharmaceuticals Short-Term Capital Lease Obligation?

Navco Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2023 was €0.00 Mil.

Navco Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Navco Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Short-Term Capital Lease Obligation Chart

Navco Pharmaceuticals Annual Data
Trend Jun18 Jun19 Jun20 Jun21
Short-Term Capital Lease Obligation
- - - -

Navco Pharmaceuticals Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Navco Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Navco Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Navco Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (FRA:F0U) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257 CTLT BOM:532321
Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Website
https://www.navcopharma.com
Navco Pharmaceuticals Inc is engaged in creating nanotechnology products using computer algorithms. The products are used in various industries like medicine, textiles, chemicals, and additives to combat microorganisms such as viruses and bacteria. Its products include aerosol sprays, hand cleansers, hand creams, and nano BioGuard(tm)-Silver.

Navco Pharmaceuticals Headlines

No Headlines